Trials / Unknown
UnknownNCT03607370
Timing for Rectal Surgery After Chemoradiotherapy
Timing for Rectal Surgery After ChST
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 142 (actual)
- Sponsor
- National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to determine whether greater rectal cancer downstaging and regression occurs when surgery is delayed to 12 weeks after completion of radiotherapy/chemotherapy compared to 8 weeks. Hypothesis: Greater down-staging and tumor regression is observed when surgery is delayed to 12 weeks after completion of chemoradiotherapy compared to 8 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Surgery after 12 weeks of delay after chemoradiotherapy. | Surgery consists oncologic resection of the rectal cancer with total excision of the mesorectum after 12 weeks of delay after the end of chemoradiotherapy. |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2023-12-31
- Completion
- 2025-12-31
- First posted
- 2018-07-31
- Last updated
- 2023-11-08
Locations
1 site across 1 country: Lithuania
Source: ClinicalTrials.gov record NCT03607370. Inclusion in this directory is not an endorsement.